# ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE

Study · id `cardio:ct-nct07452991` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07452991](<https://clinicaltrials.gov/study/NCT07452991>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07452991

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT07452991. Allocation not applicable; no masking; primary purpose treatment. Start 2024-09-10 (actual); primary completion 2029-09-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT07452991, source copy `cardio:ctgov-nct07452991-2026-03-17`, retrieved 2026-10-31)
- Started: 2024-09-10 (actual) (ClinicalTrials.gov record NCT07452991, source copy `cardio:ctgov-nct07452991-2026-03-17`, retrieved 2026-10-31)
- Primary completion: 2029-09-10 (anticipated) (ClinicalTrials.gov record NCT07452991, source copy `cardio:ctgov-nct07452991-2026-03-17`, retrieved 2026-10-31)
- Completion: 2030-09-10 (anticipated) (ClinicalTrials.gov record NCT07452991, source copy `cardio:ctgov-nct07452991-2026-03-17`, retrieved 2026-10-31)
- Countries: Russia (ClinicalTrials.gov record NCT07452991, source copy `cardio:ctgov-nct07452991-2026-03-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07452991-2026-03-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE
- Acronym: ULTRA-PE
- Condition: Pulmonary Embolism (PE)
- Intervention (Device): Ultrasound-assisted Catheter-guided Thrombolysis
- Lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (`cardio:org-national-medical-research-center-for-cardiology-ministry-of-62fee0`)

## Provenance

Content hash: 69f9f0a7a4972f6b0b4cccf2fb0fe622e56bbfe02c9b00b89018b12ea6842a5d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
